---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-055700"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T02:51:08.929674+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals closes $3.6M public offering of common stock and warrants; amends existing warrants

## Summary
- Gross proceeds of ~$3.6M from sale of 11.1M shares (or equivalents) plus Series D and E warrants at $0.3251/unit.
- Series D warrants exercisable at $0.35, expire 5 years after stockholder approval; Series E warrants expire 18 months post-approval.
- Existing Series B-1 and C-1 warrants amended: exercise price cut from $0.74 to $0.35, expiration extended to 2030 and 2026 respectively.
- Offering closed June 18, 2025; net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001213900-25-055700
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025055700/0001213900-25-055700-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025055700/ea0246131-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-055700
- JSON: https://secwatch.observer/filing/0001213900-25-055700.json
- Plain text: https://secwatch.observer/filing/0001213900-25-055700.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.